Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Krieg, Arthur
Item TypeName
Concept Toll-Like Receptors
Concept Toll-Like Receptor 4
Concept Toll-Like Receptor 9
Concept Toll-Like Receptor 2
Concept Toll-Like Receptor 7
Concept Toll-Like Receptor 1
Concept Toll-Like Receptor 8
Academic Article C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
Academic Article Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses.
Academic Article Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers.
Academic Article From A to Z on CpG.
Academic Article CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.
Academic Article Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist.
Academic Article Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
Academic Article A role for Toll in autoimmunity.
Academic Article Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
Academic Article Development of TLR9 agonists for cancer therapy.
Academic Article Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
Academic Article Toll-free vaccines?
Academic Article CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Academic Article Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.
Academic Article CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.
Academic Article Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
Academic Article Antiinfective applications of toll-like receptor 9 agonists.
Academic Article Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.
Academic Article Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist.
Academic Article TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells.
Academic Article Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
Academic Article The toll of too much TLR7.
Academic Article CpG motifs: the active ingredient in bacterial extracts?
Academic Article Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner.
Academic Article Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Academic Article TLR9 and DNA 'feel' RAGE.
Academic Article Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.
Academic Article Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression.
Academic Article Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Academic Article Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif.
Academic Article Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.
Academic Article The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.
Academic Article Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery.
Academic Article Immunology. The toll of cathepsin K deficiency.
Academic Article Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.
Academic Article Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses.
Academic Article Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
Academic Article TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.
Academic Article Therapeutic potential of Toll-like receptor 9 activation.
Academic Article Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells.
Academic Article Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.
Academic Article Immunopharmacology of CpG oligodeoxynucleotides and ribavirin.
Academic Article Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse.
Academic Article Now I know my CpGs.
Academic Article Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Academic Article Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment.
Academic Article Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila.
Academic Article Subcutaneous, but not intratracheal administration of the TLR9 agonist, CpG DNA transiently reduces parainfluenza-3 virus shedding in newborn lambs.
Academic Article Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
Academic Article Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Academic Article Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.
Academic Article CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
Academic Article Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.
Academic Article Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
Academic Article Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.
Academic Article Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy.
Academic Article Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.
Academic Article Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells.
Academic Article Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
Academic Article High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.
Academic Article Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.
Academic Article Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.
Search Criteria
  • Toll Like Receptors